Pertussis re-emergence in the post-vaccination era

Stochastic skylines

(2012) Wenjie Zhang et al.   ACM TRANSACTIONS ON DATABASE SYSTEMS

Early Impact of the US Tdap Vaccination Program on Pertussis Trends

(2012) Amanda C. Cohn   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

(2012) Lesley J. Scott et al.   BIODRUGS

Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination

(2012) S. K. Sharma et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Importance of Timing of Maternal Combined Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Immunization and Protection of Young Infants

(2012) C. Mary Healy et al.   CLINICAL INFECTIOUS DISEASES

Clinical Definitions of Pertussis: Summary of a Global Pertussis Initiative Roundtable Meeting, February 2011

(2012) J. D. Cherry et al.   CLINICAL INFECTIOUS DISEASES

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

(2012) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Can infants be protected by means of maternal vaccination?

(2012) S. Esposito et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant, Postpartum Women, and Infants

(2012) STANLEY A. GALL   CLINICAL OBSTETRICS AND GYNECOLOGY

Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

(2012) Paul L. McCormack   DRUGS

Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina

(2012) G. FABRICIUS et al.   EPIDEMIOLOGY AND INFECTION

Pertussis cocoon strategy: would it be useful for Latin America and other developing countries?

(2012) Rolando Ulloa-Gutierrez et al.   Expert Review of Vaccines

Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around…

(2012) Mark H Rozenbaum et al.   Expert Review of Vaccines

Re-emergence of pertussis: what are the solutions?

(2012) Romina Libster et al.   Expert Review of Vaccines

New pertussis vaccination approaches: en route to protect newborns?

(2012) Camille Locht et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Construction and Preliminary Immunobiological Characterization of a Novel, Non-Reverting, Intranasal Live Attenuated Whooping Cough Vaccine Candidate

(2012) R. Cornford-Nairns   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

California Pertussis Epidemic, 2010

(2012) Kathleen Winter et al.   JOURNAL OF PEDIATRICS

Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease

(2012) James D. Cherry   NEW ENGLAND JOURNAL OF MEDICINE

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why Do Pertussis Vaccines Fail?

(2012) J. D. Cherry   PEDIATRICS

Cost-effectiveness of pertussis booster vaccination in the Netherlands

(2012) Mark H. Rozenbaum et al.   VACCINE

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations

(2012) Angela Bechini et al.   VACCINE

Pertussis outbreaks and pertussis vaccines: New insights, new concerns, new recommendations?

(2012) Gregory A. Poland   VACCINE

Pertussis cases rise 10-fold among older children and adults in England and Wales

(2012) Z. Kmietowicz   BMJ-British Medical Journal

Pregnant women in UK are offered whooping cough vaccine to protect newborns

(2012) M. Billingsley   BMJ-British Medical Journal

A critical literature review of health economic evaluations in pertussis booster vaccination

(2012) Aurelie Millier et al.   Expert Review of Pharmacoeconomics & Outcomes Research

The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia

(2011) Helen Quinn et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection

(2011) L. A. Castagnini et al.   CLINICAL INFECTIOUS DISEASES

Infant Pertussis: Is Cocooning the Answer?

(2011) F. Munoz et al.   CLINICAL INFECTIOUS DISEASES

The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization

(2011) D. M. Skowronski et al.   CLINICAL INFECTIOUS DISEASES

Infant Pertussis: What to Do Next?

(2011) C. M. Healy et al.   CLINICAL INFECTIOUS DISEASES

Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

(2011) B. A. Halperin et al.   CLINICAL INFECTIOUS DISEASES

The reemergence of pertussis and infant deaths: is it time to immunize pregnant women?

(2011) Beth A Halperin et al.   Future Microbiology

Rationale for pertussis booster vaccination throughout life in Europe

(2011) Fred Zepp et al.   LANCET INFECTIOUS DISEASES

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

(2011) Elke Leuridan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis

(2011) Srinivas Garlapati et al.   VACCINE

Tdap5 Vaccine (Covaxis®)

(2010) Lesley J. Scott   BIODRUGS

Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 – Conclusions and recommendations

(2010) WHO   BIOLOGICALS

Effectiveness of Adolescent and Adult Tetanus, Reduced‐Dose Diphtheria, and Acellular Pertussis Vaccine against Pertussis

(2010) Stanley C. Wei et al.   CLINICAL INFECTIOUS DISEASES

Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands

(2010) Tjalke A. Westra et al.   CLINICAL THERAPEUTICS

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial

(2010) Jean Beytout et al.   Human vaccines & immunotherapeutics

Booster Vaccination After Neonatal Priming with Acellular Pertussis Vaccine

(2010) Markus Knuf et al.   JOURNAL OF PEDIATRICS

Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age

(2010) Nicholas Wood et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Global Pertussis Initiative: Report from a Round Table Meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11–12 January 2010

(2010) Nicole Guiso et al.   VACCINE

PERTUSSIS VACCINE EFFECTIVENESS AFTER MASS IMMUNIZATION OF HIGH SCHOOL STUDENTS IN AUSTRALIA

(2009) Claudia Rank et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population Effects

(2009) Laurent Coudeville et al.   PLoS One

Pertussis immunization in a high-risk postpartum population

(2009) C. Mary Healy et al.   VACCINE

Couverture vaccinale du personnel hospitalier du service d’urgences et de réanimation pédiatriques de l’hôpital Édouard-Herriot de Lyon en 2007, concernant la grippe, la coqueluche, la varicelle et la rougeole

(2008) L. Hees et al.   ARCHIVES DE PEDIATRIE

Poor Immune Responses to a Birth Dose of Diphtheria, Tetanus, and Acellular Pertussis Vaccine

(2008) Natasha B. Halasa et al.   JOURNAL OF PEDIATRICS

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

(2007) Markus Knuf et al.   JOURNAL OF PEDIATRICS